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William Clifford Roberts, MD,a,b,d Carlos Ernesto Velasco, MD,a Jong Mi Ko, BA,d and
Gregory John Matter, MD,c Dallas, TexAmong patients undergoing cardiac valve replacement, the
aortic valve is most commonly replaced, the mitral valve
next, and, infrequently, both the mitral and aortic valves.
When the latter situation occurs and when the substitute
valves inserted are both bioprostheses, it is possible to com-
pare the rates of degenerative change because one biopros-
thesis serves as a control for the other. In 1983, Warnes
and associates1 reported on 5 patients with porcine biopros-
theses in both the mitral and aortic valve positions from 18 to
107 months, and in each of the 4 patients in which the bio-
prosthesis was in place for greater than 18 months, the quan-
tity of calcific deposits on the cusps of the bioprosthesis in
the mitral valve position was much greater than that on the
prosthesis in the aortic valve position. The present report
was prompted by observing a patient who had a bovine pa-
rietal pericardial bioprosthesis in both the mitral and aortic
positions explanted after they had been in place for 77
months; the quantity of calcium in the bioprosthesis in the
aortic valve position was massive, and that in the bioprosthe-
sis in the mitral position was minimal.
CLINICAL SUMMARY
A patient, who was born on March 25, 1949, had acute
rheumatic fever in childhood and hypothyroidism since
age 20 years. She was in her usual good health until April
2001 (age 52 years), when exertional dyspnea appeared,
and it soon progressed to orthopnea, which prompted hos-
pital admission. Echocardiographic and cardiac catheteri-
zation data are shown in Table 1. Electrocardiographic
analysis disclosed sinus rhythm.
On May 22, 2001, both the mitral and aortic valves were
replaced with Carpentier Edwards pericardial bovine bio-
prostheses treated with the XenoLogix tissue treatment pro-
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approximately 98% of phospholipids, which are calcium-
binding sites. The excised anterior mitral leaflet weighed
0.77 g, and the 3-cuspid aortic valve weighed 0.74 g (Fig-
ure 1, A and B). Both valves were free of calcium.
The patient was thereafter well until April 2002, when
a febrile illness developed. Streptococcus sanguis was cul-
tured from the blood. She was treated with antibiotics, and
her usual health returned. Vegetations were never observed
on either bioprosthesis by means of echocardiographic
analysis. Another echocardiogram in March 2003 dis-
closed stenosis of the bioprosthesis in the aortic valve
position.
She continued to be well until August 2007, when exer-
tional dyspnea recurred, and within 3 weeks, she was essen-
tially bedridden. She was rehospitalized on September 24,
2007, and repeat cardiac catheterization (Table 1) and echo-
cardiographic analysis showed mild bioprosthetic mitral re-
gurgitation and nearly nonmovable bioprosthetic cusps in
the aortic valve position. The bioprosthesis in the aortic
valve position could not be crossed at cardiac
TABLE 1. Cardiac catheterization data in the patient presented
Variable
May 18, 2001
(before the first
operation)
October 10, 2007
(before the second
operation)
Pulmonary artery (mm Hg) 75/40 102/54
Right ventricle (mm Hg) 75/28 102/24
Right atrium (mm Hg)
A wave 30 28
V wave 23 25
Mean 22 20
Pulmonary artery wedge (mm Hg)
A wave 37 42
V wave 38 46
Mean 34 33
Left ventricle (mm Hg) 159/28
Aorta (mm Hg) 165/95 130/82
Cardiac index (L $ min 1 $ m 2) 1.8 2.0
Ejection fraction (%) 40
Body weight (lbs) 156 138
Height (inches) 62 62
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graphic analysis.
On October 12, 2007, both bioprostheses were replaced
with mechanical prostheses, and a tricuspid valve annulo-
plasty was performed. At the time of the operation, a small
paravalvular leak was seen in the mitral position. The bio-
prosthesis in the mitral position (no. 25) weighed 4.04 g,
and the bioprosthesis in the aortic position (no. 21)
weighed 3.86 g (Figure 1, C and D). Radiographs of the
operatively excised bioprostheses showed huge calcific de-
posits in the aortic prosthesis and small deposits in the mi-
tral prosthesis (Figure 2). Her postoperative course was
relatively uneventful. As of November 2008, she is active,
and her activities are not limited. By means of
FIGURE 1. Native mitral and aortic valves (A and B) and bovine pericardial bioprostheses in the mitral and aortic valve positions (C and D) in the patient
described. A, Anterior mitral leaflet from the atrial aspect and aortic valve from the ventricular aspect. B, Anterior mitral leaflet from the ventricular aspect and
aortic valve from the aortic aspect. Both native valves are devoid of calcific deposits. C, Bioprosthesis in the mitral position from the atrial aspect and biopros
thesis in the aortic position from the aortic aspect. D, Bioprosthesis in the mitral position from the ventricular aspect and bioprosthesis in the aortic position
from the ventricular aspect. Heavy calcific deposits are present on both surfaces of the bioprosthesis in the aortic valve position.
FIGURE 2. Radiograph of the bioprostheses excised from the aortic valve position (left) and the mitral valve position (right). The calcific deposits are huge
on the left and small on the right.The Journal of Thoracic and Cardiovascular Surgery c Volume 138, Number 6 1449
Brief Research Reportsechocardiographic analysis, her pulmonary arterial systolic
pressure had decreased to 34 mm Hg, and left ventricular
ejection fraction had increased to 55%. There was only
trace tricuspid valve regurgitation.
DISCUSSION
The patient described had parietal pericardial bovine bio-
prostheses in both the mitral and aortic valve positions for 77
months and during that period developed huge quantities of
calcium on the cusps of the bioprosthesis in the aortic valve
position and only small quantities of calcium on the cusps of
the bioprosthesis in the mitral valve position. Because the
closing pressure on the mitral bioprosthesis is usually about
a third higher than that on the aortic bioprosthesis (peak left
ventricular systolic pressure vs end-diastolic aortic pressure;
normally approximately 120 vs 80 mm Hg), it might be ex-
pected that the degeneration of a bioprosthesis in the mitral
position would be greater (more calcium and more tears)
and more rapid than that of a bioprosthesis in the aortic posi-
tion, but the opposite was the case in the patient described
herein. Why might that be the case? Some possibilities in-
clude the following:
1. Parietal pericardial bovine bioprostheses are not the same
as porcine aortic valve bioprostheses. The former are
thicker and less flexible and possibly withstand the left
ventricular peak systolic pressure and the aortic end-dia-Is minimized extracorporeal circulat
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2. The bovine bioprosthesis in the aortic position was defec-
tive and not properly prepared, whereas the one in the
mitral position was not.
3. The febrile illness the patient had beginning 11 months
after the initial cardiac operation could have been active
infective endocarditis that affected the bioprosthesis in
the aortic position but not the bioprosthesis in the mitral
position.
4. Smaller bovine parietal pericardial bioprostheses calcify
more rapidly and more extensively than do larger bovine
pericardial bioprostheses.
5. The paravalvular leak in the mitral position and the ab-
sence of a leak in the aortic position provided a ‘‘bypass
shunt,’’ diminishing the effect of the full force of the peak
left ventricular systolic pressure on the bioprosthetic
cusps in the mitral position.
None of these 5 possibilities can be proved or disproved,
but this report might stimulate careful follow-up of similar
patients to determine whether this distribution of calcium
in the 2 left-sided bioprostheses is a pattern or an exception.
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Perioperative red blood cell (RBC) transfusion is the single
factor most consistently associated with an increased risk of
postoperative morbid events after isolated coronary artery
bypass grafting (CABG), and each unit of RBC transfused
is associated with incrementally increased risk for adverse
outcome.1 Miniaturized extracorporeal circulation (mini-
ECC) has been proposed to limit perioperative blood prod-
uct use. Mini-ECC consists of a closed ECC system with
no cardiotomy suction or venous reservoir. The rationale is
to avoid air blood contact and minimize priming volume,
thus reducing hemostasis alteration and intraoperative
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